| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.0086 | 1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.008 | 1 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.00098 | 1 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.00081 | 1 |